Trial Profile
A trial to study safety, tolerability and monitoring of long-term filgrastim compassionate use in amyotrophic lateral sclerosis patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 May 2016
Price :
$35
*
At a glance
- Drugs Filgrastim (Primary)
- Indications Amyotrophic lateral sclerosis
- Focus Adverse reactions
- 02 May 2016 New trial record
- 21 Apr 2016 Results presented at the 68th Annual Meeting of the American Academy of Neurology